One year on: Building EUP OHAMR together
One year ago, we gathered in Brussels to launch EUP OHAMR and and embark on an ambitious ten-year journey. As we mark our first anniversary, Shahida Syed, Head of the EUP OHAMR Secretariat, reflects on our first year, why partnership matters for AMR, and her hopes for what we can achieve together in the years ahead.
One year ago, on 22–23 September 2025, we gathered in Brussels for the kick-off of the European Partnership on One Health Antimicrobial Resistance (EUP OHAMR).
There was a real sense of both opportunity and responsibility in the room. We were launching a ten-year European Partnership bringing together organisations and countries around one of the most complex global health challenges we face today: antimicrobial resistance (AMR).
Twelve months later, it feels like the right moment to reflect not only on what we have done, but on what we are building together – and why it matters.
From establishing a Partnership to putting it into action
The first year of any major partnership is necessarily about building foundations. For EUP OHAMR, that has meant turning an ambitious programme on paper into a functioning international partnership.
Over the past year, we have established our governance and ways of working, launched our first Joint Transnational Call, held our first Annual Meeting, established our scientific and strategic advisory structures, begun the development of our Stakeholder Forum, and advanced activities spanning research funding, capacity strengthening, data, policy, communication, innovation and impact.
We have also welcomed two new partners and strengthened connections with organisations and initiatives across the wider AMR, One Health and research and innovation ecosystem in Europe and internationally.
Behind these milestones has been a great deal of work, including navigating different organisations, national systems, priorities and working cultures. Perhaps my strongest reflection from this first year is that a partnership is not simply created through agreements or governance structures. It has to be built continuously through relationships, trust, shared purpose and, sometimes, compromise. It is on these foundations that we now build. The real measure of EUP OHAMR will be what this Partnership enables over the coming decade.
Why partnership matters for AMR
AMR makes the limitations of working in silos particularly visible. This is precisely why tackling AMR through a One Health lens is a necessity.
Resistance moves between humans, animals and the environment. Its drivers span healthcare, food systems, agriculture, veterinary medicine and environmental systems. Addressing it requires expertise ranging from microbiology and clinical research to social sciences, economics, implementation science, policy and innovation.
The same is true geographically. AMR does not respect borders, and addressing the research questions and developing the solutions needed requires collaboration across countries.
This is where EUP OHAMR has an important role.
By bringing together research funders, ministries, public authorities, researchers, policymakers and stakeholders over ten years, we have an opportunity to align national and shared priorities, coordinate investment, sustain commitment to AMR, build capacity, connect knowledge across sectors and countries, and strengthen the pathways through which research contributes to policy, practice and innovation.
That ability to take a long-term view is one of the Partnership’s greatest strengths, as addressing AMR requires sustained action over time.
Research must ultimately contribute to change
Another reflection from this first year is that our ambition must be both to support excellent research and to strengthen the pathways through which that research translates into impact.
We need to think from the outset about how knowledge can be used and what is needed to move from evidence to impact. This means reinforcing the science-policy interface, connecting researchers with policymakers, practitioners, innovators, patients and other end-users, and supporting implementation, innovation and the effective use and reuse of research data.
That perspective also needs to extend beyond Europe. AMR is inherently a global challenge, and EUP OHAMR sits within a much wider research and innovation ecosystem. We have an important opportunity to develop meaningful international connections, learn from different contexts and approaches, and ensure that our work both contributes to and benefits from the wider global AMR response.
Ultimately, we need to ensure that the research we support is connected to the needs of society and can contribute to meaningful and lasting change.
From foundations to delivery
Our first year has largely been about establishment and mobilisation. The coming years must increasingly be about delivery and connection.
As we move into this next phase, our focus shifts to delivering on our shared ambitions, learning and adapting as we go, and demonstrating the value of sustained collaboration on AMR.
We have an opportunity to establish EUP OHAMR as a central platform for One Health AMR research and innovation, but this also means remaining ambitious about what we can achieve together. Our joint research calls are fundamental to the Partnership, but its ten-year horizon gives us the opportunity to build on them: strengthening the wider AMR research ecosystem, creating connections that individual organisations, programmes or countries would struggle to create alone, and maximising the value and impact of our combined efforts.
A collective achievement – and a thank you
Perhaps most importantly, this anniversary is an opportunity to recognise the people behind the Partnership.
EUP OHAMR exists because organisations across many countries, together with the European Commission, have chosen to invest in AMR over the long term – not only funding, but also expertise, time and trust in a shared ambition. Much of the work involved in building a partnership happens behind the scenes, through the everyday commitment of people across our organisations who make this collaboration work.
I therefore want to extend a sincere thank you to all our partners and the many colleagues contributing across our work packages and activities, as well as to our colleagues at the European Commission for their continued support, engagement and dialogue. Your commitment is what makes this Partnership possible.
A particular thank you goes to our Coordination Unit and work package leaders, who have carried an enormous amount of responsibility during this first year and helped translate the Partnership’s ambitions into action.
I would also like to thank – and welcome – the members of our Strategic Board, Scientific Advisory Board, External Ethics Advisory Board and Stakeholder Forum, as well as the many organisations and individuals engaging with us externally. Their perspectives will be essential in ensuring that our work remains scientifically strong, strategically relevant and connected to societal needs.
Finally, a very personal thank you to the EUP OHAMR Secretariat at the Swedish Research Council. Establishing a new European Partnership while simultaneously beginning to deliver it has required flexibility, persistence and an extraordinary amount of work. I am immensely grateful for the commitment of the team, and it is a real privilege to work alongside you.
Looking ahead
When we met in Brussels a year ago, EUP OHAMR was at the beginning of a ten-year journey.
One year later, we are a growing community with a shared strategic direction and an increasingly clear sense of what we can achieve together.
There is still a great deal ahead of us. We will continue to learn and adapt, and undoubtedly encounter new challenges along the way. That is part of building something of this scale and ambition.
But there is also enormous opportunity.
The first year was about creating the Partnership.
The years ahead are about what we can achieve through it.
The EUP OHAMR General Assembly at the kick-off in Brussels 2025.
Two new partners join EUP OHAMR
We are very pleased to welcome both the Global Antimicrobial Resistance Research and Development Hub (Global AMR R&D Hub) and the Italian National Institute of Health (ISS) as new partners in the EUP OHAMR.
The addition of these organisations marks an important step in strengthening the Partnership’s expertise and international collaboration. Together, they bring extensive experience in AMR research, strategic coordination, evidence generation, and policy support, reinforcing EUP OHAMR’s mission to accelerate research and innovation through a One Health approach.
Shahida Syed, Head of Secretariat, EUP OHAMR, said:
“We are delighted to welcome both the Global AMR R&D Hub and ISS to the Partnership. Their expertise, international reach and commitment to the One Health approach will strengthen our collective efforts and enhance our ability to coordinate impactful research and innovation to tackle AMR. We look forward to working together to deliver lasting benefits for Europe and beyond.”
Lesley Ann Ogilvie, Director, Global AMR R&D Hub, said:
“AMR requires every one of us, across sectors and across nations, to bring our energy, our resources, and our commitment to building a safer, healthier world. That is why One Health AMR is more than a slogan to us—it is a guiding principle.
It is with great enthusiasm and a deep sense of honour that we join the EUP OHAMR. The Partnership’s mission to strengthen One Health research and innovation will be critical not only for Europe, but globally. We look forward to contributing the Hub’s data, insights, and expertise, and to working alongside our partners to advance our shared mission of tackling AMR through a truly One Health approach.”
Global AMR R&D Hub
The Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub is a partnership of countries, non-governmental donor organisations and intergovernmental organisations to address challenges and improve coordination and collaboration in global AMR R&D using a One Health approach.
The Hub supports governments and funders by mapping global AMR R&D investments, identifying research gaps and overlaps, and helping align funding priorities and strategies. Its Dynamic Dashboard is widely recognized as the world’s most comprehensive database of public and philanthropic AMR R&D investments. The Global AMR R&D Hub is funded by the German government and is administratively and legally hosted by the German Center for Infection Research (Deutsches Zentrum für Infektionsforschung e.V. – DZIF).
The Global AMR R&D Hub will be contributing to the EUP OHAMR Work Package 2, International Strategy Alignment and Collaboration in AMR, and Work Package 6, Knowledge valorisation to support exchange, transfer and uptake of research and innovation outcomes by end-users.
Italian National Institute of Health
The Italian National Institute of Health (Istituto Superiore di Sanità, ISS) is Italy’s leading biomedical and public health research institution and the main technical-scientific body of the National Health Service (Servizio Sanitario Nazionale, SSN). Operating under the supervision of the Ministry of Health, ISS provides scientific evidence, research and technical expertise to support public health policy and practice. Its work spans a broad range of health priorities, including AMR, infectious diseases, cancer, chronic and neurodegenerative diseases, rare diseases, and health promotion.
ISS will assume the official role of Leader of EUP OHAMR Work Package 4, Strengthening Capacity for Sustainable Antimicrobial Resistance Research, taking over from the Italian Ministry of Health. This change reflects an update in institutional affiliation, while ensuring continuity in leadership, as the same Work Package Leader will continue to guide WP4 and its activities.
Learn more about the Italian National Institute of Health (iss.it)
Success for EUP OHAMR – MSCA PF matchmaking webinar
On 25 June, the EUP OHAMR hosted the webinar "Building capacity in One Health Antimicrobial Resistance through Marie Skłodowska-Curie Actions Postdoctoral Fellowships (MSCA PF)."
The webinar brought together researchers, representatives of the European Commission, members of the EUP OHAMR, leading AMR research institutions, and Marie Sklodowska – Curie Actions (MSCA) Postdoctoral Fellows. It offered a valuable opportunity to learn more about MSCA Postdoctoral Fellowships and other funding opportunities, connect with potential host institutions, explore collaboration within the EUP OHAMR Partnership, gain first-hand insights from successful fellows, and establish new international research connections.
The event attracted nearly 100 participants from 82 countries worldwide, with particularly strong participation from low- and middle-income countries (LMICs) and Widening countries, highlighting the global interest in antimicrobial resistance research and international collaboration.
Watch the webinar (youtube.com)
Link to another websiteThe full recording from the EUP OHAMR – MSCA PF matchmaking webinar is now available.
Read more about the webinar
Link to another websiteVisit the event webpage to learn more about the webinar and explore the full programme.
The webinar was organised within the framework of the European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) with the support of the National Agency for Research and Development of the Republic of Moldova (NARD).
One Health Festival webinar recording now available
During the One Health Festival, EUP OHAMR – together with the International Society for Infectious Diseases, ICARS, and the European Partnership on Animal Health and Welfare (EUP AH&W) – organised a webinar highlighting the importance of a One Health approach to tackling antimicrobial resistance.
Key themes included collaboration, surveillance, diagnostics, biosecurity, and vaccination, all under the shared message: Why One Health is your health.
Engagement in global events: Spring highlights
In March and April, we actively engaged in a range of high‑profile global events, strengthening our visibility, networks, and strategic alignment on antimicrobial resistance (AMR) and One Health.
Inaugural Africa Fungal Disease Summit
2-3 March, Addis Ababa, Ethiopia. This landmark event convened over 100 high-level participants – policymakers, researchers, public health experts, donors, civil society and private sector partners – to catalyse Africa-led action on the rising burden of fungal infections and antifungal resistance.
The EUP OHAMR contributed to the panel Building research capability in LMICs: Lessons and Partnerships.
The event was organised by the Global Action for Fungal Infections (GAFFI) in collaboration with the Africa Centres for Disease Control and Prevention (Africa CDC).
First Americas Regional Meeting on Antimicrobial Resistance
Betsy Trainor – CARB-X, Lesley Ogillve – Global AMR R&D Hub, and Shawon Lahiri – EUP OHAMR, in a panel discussion.
23-27 March, Brasilia, Brazil. Policymakers, researchers, and practitioners from across Latin America and the Caribbean gathered to advance a shared agenda on AMR, grounded in a One Health approach.
The meeting was organised by Brazil’s Ministry of Health (Ministério da Saúde) and other national, regional, and international organisations. It provided a space for regional dialogue and collaboration, with a shared focus on accelerating action on AMR through a One Health approach.
The EUP OHAMR supported the event and presented the partnership’s goals, highlighting the value of transnational collaboration and One Health approach in a panel discussion.
Health Partnership Day
17 March, Brussels, Belgium. Following our participation in the first Health Partnership Day in October last year, we had the opportunity to present the Partnership at this year’s second Health Partnership Day. Hosted once again by DG RTD, this informal workshop brought together Programme Committee members from the Cluster 1 “Health” configuration, along with invited experts from Member States and Associated Countries, to discuss the eight Health Co-Funded Partnerships.
We were pleased to present alongside the recently launched European Partnership on Pandemic Preparedness (BeReady) and the European Partnership for Brain Health. The event provided a valuable opportunity to connect with fellow coordinators of the Health Co-Funded Partnerships and with national experts, while exchanging views on how to further strengthen the implementation and impact of Horizon Europe Co-Funded Partnerships.
One Health Expert Symposium
19 March, Brussels, Belgium. We had the pleasure of presenting the Partnership at a One Health Expert Symposium organised by the British Embassy in Brussels, where we shared perspectives on building a truly collaborative One Health research community at the European level.
The event brought together leading UK and European stakeholders to strengthen collaboration across critical cross-disciplinary areas. Opened by Professor Dame Sally Davies, the UK Special Envoy on AMR, we took part in the panel discussion on opportunities for collaboration within the One Health research community. We were pleased to contribute to the discussion and engage in the rich exchanges that followed on the operationalisation of the One Health approach, highlighting both the challenges and the opportunities ahead.
Civil Society as a Driving Force in the Global AMR Response
31 March, Brussels, Belgium. The WHO Civil Society Task Force on AMR presented their priorities and workstreams, followed by a panel discussion on ways to connect across interests and contexts with the aim of unlocking the unique values brought by civil society engagement. The seminar was co-arranged by EUP OHAMR partner organisation EPHA and the European Economic and Social Committee.
ESCMID GLOBAL 2026
Shahida Syed, EUP OHAMR, at the AMR in Action II event.
19 April, Munich, Germany. We were pleased to co-host the ESCMID Global 2026 side-event AMR in Action II alongside ICARS, and the Global AMR R&D Hub. The event brought powerful case studies on AMR diagnostics – showing both their impact and the challenge of scaling uptake beyond developing cheaper tests toward redefining their value in AMR stewardship.
Successful EUP OHAMR Annual Meeting 2026 in Vienna
During four intensive meeting days this week, the first EUP OHAMR Annual Meeting brought together members of the Partnership, policymakers, and researchers from across Europe and beyond to discuss the Partnership’s ongoing work and future priorities. The meeting included the second in-person General Assembly, as well as several side meetings held in parallel.
Grounded in the cross-cutting themes of the EUP OHAMR Strategic Research and Innovation Agenda (SRIA), the first part of the General Assembly focused on the role of social sciences, AMR as a global challenge, and how implementation science and innovation can drive impact. The session featured presentations from members of the EUP OHAMR Scientific Advisory Board (SAB), followed by a panel discussion exploring barriers and opportunities, and underscoring the importance of integrating multiple perspectives in AMR research.
Panel discussion at the General Assembly. From left: Ulrica Dohnhammar, EUP OHAMR Secretariat; Mohamed Elhadidy, SAB member; Fiona Walsh, SAB member; Jaap Wagenaar, SAB Chair; Nina Langeland, SAB Vice-Chair.
Photo: EUP OHAMR Secretrariat
During the Annual Meeting, the Scientific Advisory Board held its first in‑person meeting, and the newly established Strategic Board convened for a hybrid kick‑off meeting.
Several of the Partnership’s Work packages also took the opportunity to meet and discuss upcoming activities, and two different workshops were organised during the week:
- WP4 Workshop on Capacity building
- WP5 Workshop: Expert Consultation Session on the emerging Research Data Management framework
The EUP OHAMR Annual Meeting 2026 in Vienna was kindly hosted by the Austrian Agency for Health and Food Safety (AGES).
First Scientific Advisory Board appointed!
We are pleased to introduce the first Scientific Advisory Board (SAB) of the EUP OHAMR.
The SAB brings together 16 international experts who will provide strategic advice to the Partnership on scientific, research, innovation, and policy-related matters across the full One Health spectrum.
Jaap Wagenar, SAB Chair: “The presence of the diverse disciplines in the SAB reflects well the One Health approach of the Partnership. Members are linked to numerous other networks making the SAB a well-informed and embedded group.”
Nina Langeland, SAB Vice-Chair: “I am thrilled to take part in the scientific advice on the needs and the research gaps on AMR in Europe. The broad and complementary expertise in the SAB will strengthen our team.”
The SAB is appointed for a three-year term.
Strengthened visibility and collaboration: Autumn highlights
Over the autumn period, we have maintained a strong presence across a series of key European and global events, strengthening visibility, networks, and strategic alignment on antimicrobial resistance (AMR) and One Health.
Over the autumn period, the partnership maintained a strong presence across a series of key European and global events, strengthening visibility, networks, and strategic alignment on antimicrobial resistance (AMR) and One Health. We attended the inaugural Global AMR Innovators Conference (GAMRIC) in London (1–3 October) as exhibitors, where our OHAMR booth attracted significant interest from prospective applicants and stakeholders. This was followed by the Health Partnership Day in Brussels (8 October), providing an opportunity to exchange experiences and best practices with other initiatives within the health cluster.
Our One Health focus was further highlighted at the European One Health Association (EOHA) Side Event to the OSH4all conference in Lyon (4 November), where we presented a SWOT analysis on One Health integration within OHAMR, and at the Danish EU Presidency High-Level Conference on One Health in Copenhagen (5–6 November), where we contributed to a roundtable convened by the Danish Chief Veterinary Adviser on the future of One Health in Europe.
The EUP OHAMR secretariat at key AMR events: Danish EU Presidency High-Level Conference on One Health in Copenhagen; EU Parliamentary Event on AMR in Brussels; inaugural Global AMR Innovators Conference (GAMRIC) in London; celebration at the British Embassy in Stockholm, marking the 80th anniversary of Alexander Fleming receiving the Nobel Prize for the discovery of penicillin.
Photo credit: EUP OHAMR Secretariat
In parallel, we continued to engage with the research, policy, and end-user communities. At the BactiVac Annual Meeting in Birmingham (5–6 November), we deepened our understanding of bacterial vaccines as a powerful public health tool, while the Silver Economy Forum 2025 in Manchester (11–12 November) allowed us to participate in a roundtable on AMR, cancer, and ageing—key end-user groups highly reliant on antibiotics for effective care.
We also attended the Danish EU Presidency High-Level Meeting on AMR in Aarhus and Copenhagen (19–20 November), gaining insights into recent advances in AMR policy, and the European Patients Forum Annual Congress in Brussels (26–27 November), where we presented the Partnership and showcased how patient voices are embedded in our work.
December continued this momentum with engagement at the EU Parliamentary Breakfast Event on AMR and innovation in Brussels (3 December), where discussions focused on the EU’s new “pharma package”, MEP Stine Boss underlined the importance of basic research and discovery for driving innovation, and DG HERA highlighted OHAMR as a key EU instrument in tackling AMR. On the same day, we joined the European Partnership Stakeholder Forum, exchanging knowledge with other partnerships and learning about the European Commission’s new approach to partnerships under the forthcoming FP10.
The year concluded in Stockholm on 10 December with our attendance at the celebration marking the 80th anniversary of Alexander Fleming receiving the Nobel Prize for the discovery of penicillin, at a reception hosted by the UK at the residence of the UK Ambassador to Sweden—an inspiring reminder of the enduring impact of antimicrobial innovation.
Participate in the EUP OHAMR survey to strengthen AMR research capacity!
We are launching a survey to identify gaps in strengthening research capacity in the field of AMR. Your input is valuable!
The survey aims to conduct a global assessment of the needs, barriers (incl. logistical, legal, financial), and potential collaboration opportunities for capacity strengthening activities that EUP OHAMR can support in the coming years.
The survey covers all areas related to AMR, as well as the three challenge-driven focal areas identified in the Strategic Research and Innovation agenda (SRIA) of the Partnership – to prevent, treat and control the spread of AMR.
Please fill in the survey by 23rd December 2025, 17:00 CET through the link below. The survey takes 20–25 minutes, can be completed anonymously, and you may provide your email for feedback. Please respond based on your experience.
Your input will help strengthen AMR research capacity within the EU and beyond and foster collaboration.
Contact us if you have any questions!
Austrian Agency for Health and Food Safety (AGES)
on behalf of the EUP OHAMR Work package 4
mail OHAMR-A4.1@ages.at
Successful kick-off in Brussels for the EUP OHAMR
The European Partnership on One Health AMR has now officially kicked off after two intense days of productive meetings, and insightful talks and discussions. Watch the recording from the external part of the event to learn more about the partnership!
The kick-off on 22-23 September gathered more than 100 participants on site in Brussels to outline our objectives, align our goals, meet the EUP OHAMR team and initiate the collaborative journey ahead. Another 200 people joined online for the external part of the event to learn more about the partnership and listen to talks and knowledge sharing sessions.
Thank you to the speakers, EUP OHAMR partners and all participants for making this such a successful event!
Programme
- Welcome and Introduction
- Katarina Bjelke, Director General, Swedish Research Council, Sweden
- Kasia Jurczak, Head of Unit Combatting Diseases, DG-RDT, European Commission
- AMR: setting the scene
- Dr. Hatim Sati, AMR expert, Medical Doctor, and Public Health Professional
- An overview of the EUP OHAMR programme
- Overview of the partnership – mission, vision, scopes and functions; Shahida Syed, EUP OHAMR Head of Secretariat
- Panel discussion with Work package leads/representatives: How do we achieve our intended outputs, outcomes and impact?; Barbara Junker, WP2, DLR, Germany; Sophie Gay, WP3, ANR, France; Giorgio Vingiani, WP4, APRE, Italy; Linda van Gaalen, WP5, ZonMw, Netherlands; Francesca Hodges WP6, UKRI (MRC), United Kingdom
- Insight forum: Delivering impact through global collaboration
- Panel discussion with experts: Shawon Lahiri, moderator; Charu Kaushic, Scientific Director/Institute of Infection and Immunity (CIHR), Canada; Henning Gädeke, Chair, The European & Developing Countries Clinical Trials Partnership (EDCTP3); Helle Engslund Krarup, Director of operations, International Centre for Antimicrobial Resistance Solutions (ICARS), Hatim Sati, AMR expert; Louise Norton-Smith, Director of External Affairs, CARB-X
- Concluding remarks
- Shahida Syed, EUP OHAMR Head of Secretariat
Panel members of the Insight forum.